Your browser doesn't support javascript.
loading
Single-cell DNA-seq depicts clonal evolution of multiple driver alterations in osimertinib-resistant patients.
Chen, J; Facchinetti, F; Braye, F; Yurchenko, A A; Bigot, L; Ponce, S; Planchard, D; Gazzah, A; Nikolaev, S; Michiels, S; Vasseur, D; Lacroix, L; Tselikas, L; Nobre, C; Olaussen, K A; Andre, F; Scoazec, J Y; Barlesi, F; Soria, J C; Loriot, Y; Besse, B; Friboulet, L.
Affiliation
  • Chen J; Paris-Saclay University, Gustave Roussy, INSERM U981, Villejuif, France.
  • Facchinetti F; Paris-Saclay University, Gustave Roussy, INSERM U981, Villejuif, France.
  • Braye F; Paris-Saclay University, Gustave Roussy, INSERM U981, Villejuif, France.
  • Yurchenko AA; Paris-Saclay University, Gustave Roussy, INSERM U981, Villejuif, France.
  • Bigot L; Paris-Saclay University, Gustave Roussy, INSERM U981, Villejuif, France.
  • Ponce S; Paris-Saclay University, Gustave Roussy, INSERM U981, Villejuif, France; Drug Development Department (DITEP), Gustave Roussy, Villejuif, France.
  • Planchard D; Department of Medical Oncology, Gustave Roussy, Villejuif, France.
  • Gazzah A; Drug Development Department (DITEP), Gustave Roussy, Villejuif, France.
  • Nikolaev S; Paris-Saclay University, Gustave Roussy, INSERM U981, Villejuif, France; PRISM Institute, Gustave Roussy, Villejuif, France.
  • Michiels S; Office of Biostatistics and Epidemiology, Gustave Roussy, Oncostat U1018, INSERM, Paris-Saclay University, labeled Ligue Contre le Cancer, Villejuif, France.
  • Vasseur D; Paris-Saclay University, Gustave Roussy, INSERM U981, Villejuif, France; Experimental and Translational Pathology Platform (PETRA), Genomic Platform - Molecular Biopathology Unit (BMO) and Biological Resource Center, AMMICA, INSERM US23/CNRS UMS3655, Gustave Roussy, Paris-Saclay University, Villejui
  • Lacroix L; Paris-Saclay University, Gustave Roussy, INSERM U981, Villejuif, France; Experimental and Translational Pathology Platform (PETRA), Genomic Platform - Molecular Biopathology Unit (BMO) and Biological Resource Center, AMMICA, INSERM US23/CNRS UMS3655, Gustave Roussy, Paris-Saclay University, Villejui
  • Tselikas L; Department of Interventional Radiology, Gustave Roussy, Villejuif, France.
  • Nobre C; Paris-Saclay University, Gustave Roussy, INSERM U981, Villejuif, France.
  • Olaussen KA; Paris-Saclay University, Gustave Roussy, INSERM U981, Villejuif, France.
  • Andre F; Paris-Saclay University, Gustave Roussy, INSERM U981, Villejuif, France; Department of Medical Oncology, Gustave Roussy, Villejuif, France; PRISM Institute, Gustave Roussy, Villejuif, France.
  • Scoazec JY; Experimental and Translational Pathology Platform (PETRA), Genomic Platform - Molecular Biopathology Unit (BMO) and Biological Resource Center, AMMICA, INSERM US23/CNRS UMS3655, Gustave Roussy, Paris-Saclay University, Villejuif, France; Department of Medical Biology and Pathology, Gustave Roussy, V
  • Barlesi F; Department of Medical Oncology, Gustave Roussy, Villejuif, France; Aix Marseille University, CNRS, INSERM, CRCM, Marseille, France.
  • Soria JC; Department of Medical Oncology, Gustave Roussy, Villejuif, France.
  • Loriot Y; Paris-Saclay University, Gustave Roussy, INSERM U981, Villejuif, France; Department of Medical Oncology, Gustave Roussy, Villejuif, France.
  • Besse B; Paris-Saclay University, Gustave Roussy, INSERM U981, Villejuif, France; Department of Medical Oncology, Gustave Roussy, Villejuif, France.
  • Friboulet L; Paris-Saclay University, Gustave Roussy, INSERM U981, Villejuif, France. Electronic address: luc.friboulet@gustaveroussy.fr.
Ann Oncol ; 33(4): 434-444, 2022 04.
Article in En | MEDLINE | ID: mdl-35066105

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2022 Document type: Article Affiliation country: Francia

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2022 Document type: Article Affiliation country: Francia